During the 2020 Ipnet General Assembly on December 4th, 2020, 5 presentations came out from the Scientific Meeting. There are videos available following the links below.
1. Givosiran: Efficacy, safety and therapeutic scheme, by Eliane Sardh, Stockholm:
2020 status of Givosiran, by Eliane Sardh
2. Iron deficiency as a treatment of CEP, by Emmanuel Richard, Bordeaux:
Iron deficiency: a treatment of CEP, by Emmanuel Richard
3. Generation and Characterization of an Inducible Hepatocyte-specific ALAS1 Knockout Mouse
Model, by Makiko Yasuda, New York
4. Farewell Biorad: MS methods for PBG/ALA, by Thibaud Lefebvre, Paris
2020 MS methods for PBG/ALA, by Thibaud Lefebvre
5. Highlights from the MT-7117 Dersimelagon Phase 2 Muticenter, Double-Blind, Placebo-
Controlled Trial in 102 EPP Patients, by Robert Desnick, New York
The ICPP originally planned for September 2026 has been postponed due to the recent conflict in the Middle East. It will now take place from 14-17 March 2027. The conference is expected to be held in Istanbul but a final decision on the location will be confirmed in early September. All submission and registration deadlines will be extended in line with the new dates. If you have already registered for ICPP2026, please contact the organisers directly on icpp2026@bumeranggroup.com.